Angiotensin‐converting enzyme inhibitors increase anti‐fibrotic biomarkers in African Americans with left ventricular hypertrophy

Abstract Angiotensin‐converting enzyme inhibitors (ACEi) are part of the indicated treatment in hypertensive African Americans. ACEi have blood pressure‐independent effects that may make them preferred for certain patients. We aimed to evaluate the impact of ACEi on anti‐fibrotic biomarkers in Afric...

Description complète

Détails bibliographiques

Auteurs principaux:	Cesar A.Romero, Shobi Mathew, Benjamin Wasinski, Brian Reed, Aaron Brody, Rachelle Dawood, Michael J. Twiner, Candace D. McNaughton, Rafael Fridman, John M. Flack, Oscar A. Carretero, Phillip D. Levy
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2021-05-01
Collection:	The Journal of Clinical Hypertension
Sujets:	ACE inhibitors Ac‐SDKP African American collagen left ventricular hypertrophy MMP‐1
Accès en ligne:	https://doi.org/10.1111/jch.14206
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!